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Case Report 
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Parathyroid Tumour in a Patient with 
Primary Hyperparathyroidism
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The association of monoclonal gammopathies with primary hyperparathyroidism is well documented.
Many case reports have documented the coexistence of primary hyperparathyroidism and multiple
myeloma. The cause of this relationship is not known. We report the case of a 49-year-old gentleman who
was treated for primary hyperparathyroidism. His initial preoperative nuclear scan had shown persistent
activity and retention of tracer in the retrosternal region in addition to the discrete hot spot in the region
of the lower pole of the left lobe of the thyroid. During surgery, the enlarged left inferior parathyroid gland
was removed. In addition, the retrosternal area was also explored and found to be normal. Ten months later,
he developed a mass in the region of the manubrium sternii which was proven to be a plasmacytoma. We
review the literature for similar cases and suggest hypotheses for a possible association. In conclusion,
coexisting plasma cell dyscrasias including plasmacytoma should be considered in patients with primary
hyperparathyroidism. [Asian J Surg 2007;30(2):147–50]
Key Words: intact parathyroid hormone, monoclonal gammopathy, plasmacytoma, primary hyper-
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Introduction
The association of monoclonal gammopathy (MG) with
primary hyperparathyroidism (PHPT) is well documented.
The first patient with PHPT and MG was described 
by Clubb et al.1 The patient had disappearance of the
monoclonal immunoglobulin after successful resection of
parathyroid adenoma. A number of case reports of primary
hyperparathyroidism coexisting with multiple myeloma are
available in the literature.2–15,18 The association suggests a
possible link between the two conditions. However, other
case reports have not documented any postoperative disap-
pearance of monoclonal immunoglobulin after successful
excision of the parathyroid tumour. Therefore, the rela-
tionship between the two disorders is still undetermined.
We report a case of a 49-year-old gentleman who under-
went bilateral neck exploration and excision of left infe-
rior parathyroid adenoma. He presented to us within 
6 months of successful surgery with a single plasmacytoma.
To the best of our knowledge, this is the first case report
documenting these two disorders in the same patient.
Case report
A 49-year-old man was referred to us with symptomatic
renal calculi and bilateral hydronephrosis. On work up
for metabolically active renal stone disease, he was found to
have repeated high calcium values with normal inorganic
phosphorus and a mildly deranged renal function. Serum
intact parathyroid hormone (PTH) values were found to
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be elevated. The details of his laboratory tests are given in
the Table. An ultrasound of the neck detected a single 
large adenoma in the region of the left inferior parathy-
roid gland. The technetium (Tc99) sestambi scan showed
uptake consistent with a left inferior parathyroid ade-
noma. There was additional uptake in the region of the
manubrium sternii (Figure 1) which was reported as a
possible second retrosternal adenoma. He underwent
bilateral neck exploration and a parathyroid adenoma
around 4 cm in diameter was removed from the region of
the left inferior parathyroid gland. The presence of increased
uptake in the region of the manubrium sternii on delayed
sestamibi imaging prompted an exploration of the sub-
sternal region and inspection of the manubrium sternii
was carried out intraoperatively with negative results. 
The other glands were normal on inspection. Histopa-
thological examination was consistent with a parathyroid
adenoma (Figure 2). The patient had an uneventful recovery
with normalization of serum calcium levels.
Ten months later, the patient presented to us with a
painful progressive swelling in the region of the upper
sternum of 6 months duration. Computed tomography
imaging suggested a vascular mass arising superficially
from the sternum (Figure 3). His biochemical and haema-
tological parameters were normal. Fine needle aspiration
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Table. Selected initial laboratory values prior to parathyroid 
surgery
Laboratory tests Results Normal range
Calcium (mmol/L) 2.85 2.08–2.60
Phosphorus (mmol/L) 1.13 0.81–1.49
PTH plasma (ng/L) 1,416 8.0–74.0
Alkaline 128 40–125
phosphatase (U/L)
Creatinine (μmol/L) 150.3 44.2–123.8
2 hr
LT lateral
2 hr
Anterior
10 min
Figure 1. Early and delayed images of parathyroid scintigraphy show persistent
activity in the left lower neck region and washout of activity from thyroid lobes.
Retrosternal region shows some retention of tracer.
cytology suggested a neoplastic lesion. He underwent 
a Trephine biopsy of the mass. The histopathology was
consistent with a plasmacytoma (Figure 4). Bone marrow
aspirate did not show any increase in plasma cells. A diag-
nosis of plasmacytoma was established. He was referred
for radiotherapy.
Discussion
This case represents the first documentation of the coex-
istence of primary hyperparathyroidism with plasmacytoma.
A review of the literature reveals at least 17 cases where
PHPT coexisted with multiple myeloma.1–15,18 In a major-
ity of the cases reported, the patients were elderly and a
plausible consideration is simple coincidence of the two
disorders. However, there is a single prospective study that
has shown a significant increase in the prevalence of MG
in patients with PHPT.
The prevalence of MG in healthy population is esti-
mated to be approximately 1% by several large analyses of
electrophoretic data in different populations.16,17 The
prevalence increases with age and may be as high as 6.1%
in healthy individuals older than 70 years.16 In contrast,
the prevalence of MG in adults < 50 years old is low (0.2%).
A recent prospective study looked at 101 consecutive
patients with PHPT in whom serum immunoglobulin
was systematically studied using agarose gel electrophoresis
and immunofixation before and after parathyroid surgery.
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Figure 2. Haematoxylin and eosin stain of the left inferior
parathyroid adenoma under 400× magnification.
Figure 3. Computed tomography shows the plasmacytoma in
relation to the manubrium sternii.
Figure 4. (A) Haematoxylin and eosin stain of the sternal plasmacytoma under 400× magnification shows plasma cells with atypical nuclei
(thin arrow) and binucleation (thick arrow). (B) Positive staining for CD138 and (C) negative staining for CytoK immunostaining.
MG was detected in 10% of patients with PHPT and this
included two patients in whom it was associated with
multiple myeloma compared to 2% among 127 patients
who underwent other surgeries.18
In patients reported with myeloma and PHPT, the com-
monest presentation was the recurrence of hypercalcaemia
after successful parathyroid surgery with suppressed PTH
levels.3 Other patients presented with hypercalcaemia in
multiple myeloma which was unresponsive to therapy
directed at the tumour and had elevated PTH levels. Subse-
quent localization and excision of the coexisting parathyroid
tumour restored the serum calcium to normal levels.2
The relationship between MG and PHPT remains spec-
ulative. Soluble factors secreted by one type of tumour cell
may trigger the growth of the other. Monoclonal immuno-
globin may act as a growth factor for parathyroid cells as
does the immunoglobin G called thyroid stimulating anti-
bodies on thyroid cells.19 Alternatively, PTH may stimulate
osteoblastic cells to secrete high levels of interleukin-6.20
This elevated cytokine level plays a key role in develop-
ment of a plasma cell disorder.21 High PTH levels may fur-
ther facilitate the emergence and growth of the plasma
cell clone.
Sporadic hyperparathyroidism is associated with over-
expression of the proto-oncogene PRAD1/cyclin 1 (parathy-
roid adenoma 1) on chromosome 11q13 in a significant
number of patients. This gene encodes a cyclin protein called
cyclin D1 which may play an important role in the control
of cell cycle at the G1-S transition. Subsequent reports have
associated the overexpression of this gene in various types
of B cell lymphomas, myelomas and other solid tumours.22
Thus, it is speculated that an inherited or acquired gene
defect may predispose a patient to both these diseases.
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